Table 4.
Gender | No. examined | Anti-Leishmania antibody titers | Total | |||||
---|---|---|---|---|---|---|---|---|
1:400 | 1:800 | 1:1600 | ≥1:3200 | |||||
No.Prevalence (%) | No.Prevalence (%) | No.Prevalence (%) | No.Prevalence (%) | No.Prevalence (%) | ||||
Male | 800 | 10 | 12 | 10 | 1 | 33 | ||
0.63 | 0.76 | 0.63 | 0.06 | 2.1 | ||||
Female | 764 | 6 | 8 | 6 | 0 | 0 | 20 | |
0.38 | 0.51 | 0.38 | 1.27 | |||||
Total | 1564 | 16 | 20 | 16 | 1 | 53 | ||
1.01 | 1.28 | 1.01 | 0.06 | 3.38 |